Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population

LESSONS LEARNED. Modification of FOLFIRINOX significantly improves safety and tolerability in Chinese patients with locally advanced pancreatic cancer. Patients with locally advanced pancreatic cancer benefit from neoadjuvant therapy and experience a much better survival than patients with upfront s...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: Li, Xiang, Guo, Chengxiang, Li, Qinghai, Wei, Shumei, Zhang, Qi, Chen, Yiwen, Shen, Yinan, Ma, Tao, Li, Guogang, Gao, Shunliang, Que, Risheng, Lou, Jianying, Yu, Risheng, Yuan, Ying, Wei, Qichun, Huang, Pintong, Liang, Tingbo, Bai, Xueli
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Inc. 2018
Предметы:
Clinical Trial Results
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519772/
https://ncbi.nlm.nih.gov/pubmed/30459238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0696
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы